Chronic rejection in non-human primates: Sirolimus (rapamycin), but not cyclosporin, prevents graft vascular disease (GVD) in aortic allografts alter acute rejection. Ikonen, T. S., Gummert, J. F., Hayase, M., Honda, Y., Kobayashi, Y., Christians, U., Hausen, B. A., Berry, G. J., Yock, P. G., Morris, R. E. LIPPINCOTT WILLIAMS & WILKINS. 1999: S252–S252

View details for Web of Science ID 000079910701004